215 related articles for article (PubMed ID: 37321107)
1. Quinolone analogues of benzothiazinone: Synthesis, antitubercular structure-activity relationship and ADME profiling.
Dube PS; Legoabe LJ; Jordaan A; Sigauke L; Warner DF; Beteck RM
Eur J Med Chem; 2023 Oct; 258():115539. PubMed ID: 37321107
[TBL] [Abstract][Full Text] [Related]
2. Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activity.
Dube PS; Legoabe LJ; Jordaan A; Jesumoroti OJ; Tshiwawa T; Warner DF; Beteck RM
Eur J Med Chem; 2021 Mar; 213():113207. PubMed ID: 33524688
[TBL] [Abstract][Full Text] [Related]
3. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
[TBL] [Abstract][Full Text] [Related]
4. 6-Nitro-1-benzylquinolones exhibiting specific antitubercular activity.
Beteck RM; Jordaan A; Swart T; Van Der Kooy F; Warner DF; Hoppe HC; Legoabe LJ
Chem Biol Drug Des; 2020 Dec; 96(6):1387-1394. PubMed ID: 32558257
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
Liu L; Kong C; Fumagalli M; Savková K; Xu Y; Huszár S; Sammartino JC; Fan D; Chiarelli LR; Mikušová K; Sun Z; Qiao C
Eur J Med Chem; 2020 Dec; 208():112773. PubMed ID: 32898793
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis.
Piton J; Vocat A; Lupien A; Foo CS; Riabova O; Makarov V; Cole ST
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012754
[TBL] [Abstract][Full Text] [Related]
8. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
[TBL] [Abstract][Full Text] [Related]
9. Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents.
Fan D; Wang B; Stelitano G; Savková K; Shi R; Huszár S; Han Q; Mikušová K; Chiarelli LR; Lu Y; Qiao C
J Med Chem; 2021 Oct; 64(19):14526-14539. PubMed ID: 34609861
[TBL] [Abstract][Full Text] [Related]
10. Mutations in
Poulton NC; Azadian ZA; DeJesus MA; Rock JM
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0090422. PubMed ID: 35920665
[TBL] [Abstract][Full Text] [Related]
11. Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity.
Fan D; Wang B; Stelitano G; Savková K; Riabova O; Shi R; Wu X; Chiarelli LR; Mikušová K; Makarov V; Lu Y; Hong Y; Qiao C
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509615
[TBL] [Abstract][Full Text] [Related]
12. Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents.
Sahoo SK; Gajula SNR; Ahmad MN; Kaul G; Nanduri S; Sonti R; Dasgupta A; Chopra S; Yaddanapudi VM
Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200168. PubMed ID: 35876343
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis.
Guo S; Fu L; Wang B; Chen X; Zhao J; Liu M; Lu Y
Biomed Pharmacother; 2020 Nov; 131():110777. PubMed ID: 33152936
[TBL] [Abstract][Full Text] [Related]
14. Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes.
Liu R; Lyu X; Batt SM; Hsu MH; Harbut MB; Vilchèze C; Cheng B; Ajayi K; Yang B; Yang Y; Guo H; Lin C; Gan F; Wang C; Franzblau SG; Jacobs WR; Besra GS; Johnson EF; Petrassi M; Chatterjee AK; Fütterer K; Wang F
Angew Chem Int Ed Engl; 2017 Oct; 56(42):13011-13015. PubMed ID: 28815830
[TBL] [Abstract][Full Text] [Related]
15. Synthetic molecules as DprE1 inhibitors: A patent review.
Imran M; A S A; Thabet HK; Abida ; Afroz Bakht M
Expert Opin Ther Pat; 2021 Aug; 31(8):759-772. PubMed ID: 33709862
[TBL] [Abstract][Full Text] [Related]
16. Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis.
Richter A; Narula G; Rudolph I; Seidel RW; Wagner C; Av-Gay Y; Imming P
ChemMedChem; 2022 Mar; 17(6):e202100733. PubMed ID: 34939744
[TBL] [Abstract][Full Text] [Related]
17. Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors.
Chandran M; Renuka J; Sridevi JP; Pedgaonkar GS; Asmitha V; Yogeeswari P; Sriram D
Int J Mycobacteriol; 2015 Jun; 4(2):104-15. PubMed ID: 26972878
[TBL] [Abstract][Full Text] [Related]
18. Towards a new combination therapy for tuberculosis with next generation benzothiazinones.
Makarov V; Lechartier B; Zhang M; Neres J; van der Sar AM; Raadsen SA; Hartkoorn RC; Ryabova OB; Vocat A; Decosterd LA; Widmer N; Buclin T; Bitter W; Andries K; Pojer F; Dyson PJ; Cole ST
EMBO Mol Med; 2014 Mar; 6(3):372-83. PubMed ID: 24500695
[TBL] [Abstract][Full Text] [Related]
19. 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1.
Finger V; Kucera T; Kafkova R; Muckova L; Dolezal R; Kubes J; Novak M; Prchal L; Lakatos L; Andrs M; Hympanova M; Marek J; Kufa M; Spiwok V; Soukup O; Mezeiova E; Janousek J; Nevosadova L; Benkova M; Kitson RRA; Kratky M; Bősze S; Mikusova K; Hartkoorn R; Roh J; Korabecny J
Eur J Med Chem; 2023 Oct; 258():115611. PubMed ID: 37421887
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
